Media & Resources

The International AIDS Vaccine Initiative (IAVI) issued this statement on February 20, 2007 following an announcement made by the Canadian government and the Bill & Melinda Gates Foundation to pledge up to CAD$139 million for the creation of a Canadian HIV Vaccine Initiative (CHVI). The new CHVI will contribute to the global effort to develop…

“Vaccines for the Future Act of 2007” Calls for Financial Support for Advance Market Commitments The International AIDS Vaccine Initiative (IAVI) applauds Senator Richard Lugar (R-Indiana) for his leadership in introducing “Vaccines for the Future Act of 2007” legislation. His proposal calls for a comprehensive strategy to speed the development, testing and distribution of vaccines…

he International AIDS Vaccine Initiative (IAVI) applauds the governments of Canada, Italy, Norway, Russia and the United Kingdom, as well as the Bill & Melinda Gates Foundation for their leadership and generosity in establishing a pilot Advance Market Commitment (AMC) program, an innovative financing mechanism aimed at accelerating the research, development and production of new…

The International AIDS Vaccine Initiative (IAVI) mourns the tragic death of our friend and colleague, Professor Job Joab Bwayo, co-founder and director of the Kenya AIDS Vaccine Initiative (KAVI) in Nairobi, Kenya. Prof. Bwayo, a passionate AIDS advocate, dedicated much of his distinguished career to developing an HIV vaccine for communities throughout the African continent.…

IAVI Issues Annual Map of AIDS Vaccine Research Activity Worldwide NEW YORK, January 31, 2007 — The International AIDS Vaccine Initiative’s (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world…

Seeking Novel Protein Design to Help Solve the Neutralizing Antibody Problem Mass. General, MIT WALTHAM, MA, Dec 17, 2008 — InnoCentive, Inc., the global innovation marketplace, today announced that the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use…

Testimonials to Help Raise Global Support for AIDS Vaccine Development New York, December 1, 2008—On the 20th anniversary of World AIDS Day, the International AIDS Vaccine Initiative (IAVI) invites individuals from around the world to show their support for the development of an AIDS vaccine by contributing their voices to a new gallery of video…

London, 27 November 2008 –  The International AIDS Vaccine Initiative (IAVI) and the St. Stephen’s AIDS Trust at the Chelsea and Westminster Hospital have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates. “Prevention is crucial in the fight against HIV and AIDS, and a…